LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug YL202 targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called YL202 in about 100 people with advanced solid tumors, including lung, colorectal, and cervical cancers that have not responded to other treatments. The main goal is to see if the drug can shrink tumors, while also checking for side eff…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 02:31 UTC
-
New hope for advanced cancers: experimental drug MRG007 enters human testing
Disease control Recruiting nowThis early-phase study tests an experimental drug called MRG007 in people with advanced solid tumors (like colorectal, gastric, or pancreatic cancer) that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects, while also seei…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated May 26, 2026 02:26 UTC
-
New cancer drug enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug called ANS014004 in about 63 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must have a specif…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 02:25 UTC
-
New hope for advanced cancers: XB010 trial launches
Disease control Recruiting nowThis early-phase study tests a new drug called XB010, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for any side effects. About 396 adults with…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated May 26, 2026 02:25 UTC
-
New hope for advanced cancer patients as YL202 enters phase II trial
Disease control Recruiting nowThis study tests a new drug called YL202 in about 200 people with advanced solid tumors, including lung, breast, and head/neck cancers. The goal is to see if the drug can shrink tumors and how safe it is. Participants must be between 18 and 75 years old and have tried other treat…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 02:24 UTC
-
New drug enzelkitug takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new drug, enzelkitug, given alone or with standard immunotherapy drugs, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety and find the right dose. About 450 adults with cancers like lung, …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC